Abstract submissions are open for POEM 4th Scientific Meeting

Abstract submissions are now open for upcoming POEM 4th Scientific Meeting planned to be held in Amman, Jordan on May 1-3, 2025.

This meeting will bring together leading experts, researchers, and professionals to share advancements and foster collaboration in the field. Don’t miss the opportunity to present your work at this prestigious event and connect with a global audience.

Abstract submission deadline: February 1st, 2025.

Submit your work to be featured at the conference! Best Abstracts will be receiving travel grants to participate in the Scientific Meeting.

Submission Rules:

1. Abstracts must be submitted exclusively through the online form by the specified deadline; submissions via email will not be accepted.

2. Incomplete studies or abstracts with statements like “Results will be discussed in the conference” will be rejected.

3. Clinical Trials in Progress abstracts are eligible for submission.

4. Case reports are accepted.

5. While new research projects are encouraged, studies previously presented or published at National, Regional, or International meetings since May 1, 2024, are also eligible. If applicable, clearly indicate where and when the study was previously presented.

6. Research projects relevant to the POEM region will be prioritized.

7. The presenting author must ensure there are no conflicts of interest, confirm that all co-authors are aware of the abstract content, and obtain their approval before submission.

8. Abstracts must be written in proper English with accurate grammar.

9. Authors will be notified of successful abstract submissions by the review committee.

10. If an abstract is accepted, failure by the presenting author to register for the conference may result in the withdrawal of the abstract.

11. Each individual may submit and serve as the presenting author for up to five abstracts.

Guidelines for Abstract Content:

1. Use abbreviations sparingly and only for commonly recognized terms.2. Avoid referring to patients by their diseases. For instance, use “patients with [disease]” instead of “[disease] patients.”

3. Only generic drug names are allowed; abstracts must not include promotional or commercial content.

4. Exclude patient names or any identifying information.

5. Use commas for numbers over 999 (e.g., 1,000).

6. Use periods for decimal numbers (e.g., 2.59, not 2,59).

7. Place a zero before decimal numbers less than 1 (e.g., 0.75, not .75).

8. Report all measurements using metric units.

9. When a sentence begins with a number, write it in words (e.g., “Two patients…” instead of “2 patients…”).

10. Do not submit duplicate copies of the same abstract.

About POEM

The Pediatric Oncology East and Mediterranean (POEM) Group was established in 2013 as a cooperative platform aimed at uniting healthcare professionals, physicians, and researchers from institutions across the East and Mediterranean regions. The group’s mission is to foster collaboration by sharing expertise, initiating joint clinical trials, and developing common strategies to optimize pediatric oncology care.

In addition to promoting cooperation in clinical research, the POEM Group focuses on capacity-building efforts, including training healthcare providers, raising awareness, and establishing pediatric oncology centers in underserved areas.

Through these initiatives, POEM aims to improve diagnosis, treatment outcomes, and long-term care for pediatric oncology patients, contributing to the overall global effort to enhance survival rates and quality of life for children with cancer in the region.

POEM 2025